SPHAERO
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
FR
EN
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
EH
Emna Harigua‐Souiai
Publications (11)
Repurposing approved drugs targeting Leishmania infantum 5-Methylthioadenosine Phosphorylase as anti-leishmanial candidates
Article scientifique · 2026
AIR-LEISH: A Dataset of Giemsa-Stained Microscopy Images for AI-based Leishmania amastigotes Detection
Article scientifique · 2026
Tranylcypromine: a promising repurposed drug against Leishmaniases
Article scientifique · 2026
Recombinase-based amplification coupled with lateral flow chromatography for the specific and sensitive detection and identification of Leishmania major in cutaneous leishmaniasis patients
Article scientifique · 2025
cidalsDB: an AI-empowered platform for anti-pathogen therapeutics research
Article scientifique · 2024
Approved drugs successfully repurposed against Leishmania based on machine learning predictions
Article scientifique · 2024
Exploring AI governance in the Middle East and North Africa (MENA) region: gaps, efforts, and initiatives
Article scientifique · 2024
ANTIPSEUDOBASE: Database of Antimicrobial Peptides and Essential Oils against Pseudomonas aeruginosa
Article scientifique · 2022
Deep Learning Algorithms Achieved Satisfactory Predictions When Trained on a Novel Collection of Anticoronavirus Molecules
Article scientifique · 2021
Dipeptidyl peptidase III as a DNA marker to investigate epidemiology and taxonomy of Old World Leishmania species
Article scientifique · 2021
Lesionia: a digital data management system for epidemiological and clinical data collected from patients suspected for cutaneous leishmaniasis
Article scientifique · 2020
Domaines principaux
Sciences de la santé
7
Sciences mathématiques et statistiques
3
Informatique et sciences numériques
3
Sciences sociales et comportementales
1
Statistiques
Consultations
10
Téléchargements
0
Votre avis compte
Une suggestion, un bug, un ressenti sur SPHAERO ? Une minute suffit.
Plus tard
Donner mon avis
Votre avis compte
Nom
(optionnel)
Courriel
(optionnel)
Type de retour
Suggestion
Avis général
Signaler un bug
Message
Annuler
Envoyer
Merci, votre message a bien été envoyé.